Anti-Hu CD5 Pacific Blue™

*Guarne A, Bravo J, Calvo J, Lozano F, Vives J, Fita I: Conformation of the hypervariable region L3 without the key proline residue. Protein Sci. 1996 Jan;5 (1) :167-9. , URL: https://www.ncbi.nlm.nih.gov/pubmed/8771210?dopt=A, *Leukocyte Typing III., McMichael A. J. et al. (Eds.), Oxford University Press (1987) ., URL: , *Arrizabalaga P, Mirapeix E, Darnell A, Torras A, Revert L: Cellular immunity analysis using monoclonal antibodies in human glomerulonephritis. Nephron. 1989;53 (1) :41-9., URL: https://www.ncbi.nlm.nih.gov/pubmed/2789343?dopt=A, *Alberola-Ila J, Places L, Cantrell DA, Vives J, Lozano F: Intracellular events involved in CD5-induced human T cell activation and proliferation. J Immunol. 1992 Mar 1;148 (5) :1287-93., URL: https://www.ncbi.nlm.nih.gov/pubmed/1371522?dopt=A

*Freedman AS, Freeman G, Whitman J, Segil J, Daley J, Levine H, Nadler LM: Expression and regulation of CD5 on in vitro activated human B cells. Eur J Immunol. 1989 May;19 (5) :849-55. , URL: https://www.ncbi.nlm.nih.gov/pubmed/2472277?dopt=A, *Raman C: CD5, an important regulator of lymphocyte selection and immune tolerance. Immunol Res. 2002;26 (1-3) :255-63., URL: https://pubmed.ncbi.nlm.nih.gov/12403363/